The NutriPharma Coalition is a collaboration between natural ingredient companies, nutraceutical scientists and open-minded pharmaceutical companies to develop patented nutraceutical medicines solving many of the health issues facing the average health care patient at an affordable cost. According to Pharma Manufacturing Magazine, the average cost to develop a new pharma drug is $800 million. Much of the expense is due to the need to prove safety of the drug molecule and meeting all the requirements put forth by the FDA (U.S. Food and Drug Administration).
The mission of the Coalition is to replace the chemicals used to develop patented drugs with 100 percent natural ingredients with zero toxicity. These new natural medicines will be scientific formulations made up of proven natural ingredients backed by clinical trials proving their effectiveness on selected health conditions. These formulas will be patented to protect the developing parties and run through clinical trials against already proven drugs for that selected health condition.
The first two founding members of the Coalition are:
Nag Research Laboratories Inc. (NRL) is a California-based research and development company established in 1996. NRL has conducted its core business in biotechnology, pharmaceuticals and herbal sciences for almost three decades. In 2018, NRL entered a joint collaboration program with GCI Nutrients Inc., a global leader in supplying herbal and other ingredients to the nutraceutical industry, supported by scientific and clinical data. GCI is based in Burlingame, CA, conducting its core business in supplying bulk natural product ingredients for almost 50 years.
Both NRL and GCI with their complementary skills are exploring to introduce high-quality active ingredients supported by state-of-the art scientific research and clinical research to develop superior health solutions. The team’s strengths include optimizing high quality ingredients with the potential of obtaining intellectual property rights. Their major mission is helping companies to create formulas that compare favorably with pharmaceuticals in terms of effectiveness, safety and cost.
Since 2018, GCI has introduced a list of standardized active ingredients for more than 50 health conditions for which pre-clinical and clinical results are available. With more than 3,000 scientific publications in a combined database for all these active ingredients, GCI and NRL are able to produce creative formulations for the nutraceutical industry, according to the companies.
NutriPharma’s strength in scientific research includes over 100 animal models representing major health conditions, pharmacokinetics studies to improve bioavailability of active ingredients and creative patentable final formulations. The team has more than 100 U.S. and international patents in the field of active formulations, molecules and natural product ingredients. In addition, the joint collaboration allows for the opportunity to conduct cost-effective global clinical trials parallel with best of class pharmaceutical drugs. As a result, the NutriPharma team can provide full support to the industry in bringing natural product ingredients to the next generation at an affordable cost, the company stated.
It is the goal of the Coalition to share and develop future nutraceutical solutions by using all the testing tools available to clinically prove the effectiveness of these formulas. The Coalition is currently conducting six clinical trials around the world.